This content is from: Premium Wachtell Lipton Calls on SEC to Protect Against Activists The New York firm, whose co-founder is credited with inventing the poison pill, says the SEC needs to help protect firms against unwanted activist attacks. By Stephen Taub March 31, 2014
This content is from: Premium Wachtell Goes on the Activist Warpath (Again) The law firm widely credited with inventing the poison pill wants the SEC to change rules affecting how and when activists disclose their stakes. By Stephen Taub September 28, 2015
This content is from: Premium Activist Battle Turns Academic New York lawyers and a group of academics square off over whether activist investors should be loathed or loved. By Stephen Taub September 20, 2013
This content is from: Corner Office Lipton, Peltz Call BlackRock’s Letter a Blueprint for Shareholder Engagement Martin Lipton of Wachtell, Lipton, Rosen & Katz says his firm sent a memo to clients that called the missive a roadmap for engaging investors. By Alicia McElhaney January 19, 2018
This content is from: Portfolio Fight Brews over SEC's Blockholder Disclosure Rules The law firm that invented the poison pill defense wants investors to report more quickly when they grab more than 5 percent of a company's stock. Other shareholder activists disagree. A long, drawn-out fight beckons. By Stephen Taub March 27, 2012
This content is from: Premium As Proxy Wars Spread, Governance Questions Arise Do hedge fund activists disadvantage longer-term shareholders in the process of ‘unlocking’ shareholder value? By Stephen Taub March 12, 2013
